日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL

在接受天冬酰胺酶治疗的急性淋巴细胞白血病(ALL)患者中,建立并进行静脉血栓栓塞风险预测模型的外部验证

Anderson, Daniela R; Gangaraju, Radhika; Sedhom, Wafik George; Hamulyák, Eva N; Wang, Tzu-Fei; O'Dwyer, Kristin; Carney, Brian J; Muthiah, Chandrasekar; Liedtke, Michaela; Badar, Talha; Shimony, Shai; Robinson, Renana; Sanfilippo, Kristen; Derkach, Andriy; Dinner, Shira; Biemond, Bart J; Nemirovsky, David; Goldberg, Leah A; Kapadia, Anjani D; Levavi, Hannah; Bar-Natan, Michal; Van Hyfte, Grace; Bansal, Karan; Carrier, Marc; Fulcher, Jill; Gerrits, Anke M; Litzow, Mark R; Luger, Selina; Guru Murthy, Guru Subramanian; Luskin, Marlise; Wolach, Ofir; Shomali, William; Zwicker, Jeffrey I; Stock, Wendy; Leader, Avi

The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

ENHANCE-3 研究:维奈托克和阿扎胞苷联合马格罗利单抗或安慰剂治疗不适合强化治疗的初治急性髓系白血病

Daver, Naval; Vyas, Paresh; Huls, Gerwin; Döhner, Hartmut; Maury, Sébastien; Novak, Jan; Papayannidis, Cristina; Martínez Chamorro, Carmen; Montesinos, Pau; Niroula, Rabin; Fenaux, Pierre; Esteve, Jordi; Wu, Shang-Ju; De Voeght, Adrien; Mayer, Jiri; Valk, Peter J M; Johnson, Lisa; Dong, Mei; Liu, Ke; Kuwahara, Sowmya; Caldwell, Kenneth; Guru Murthy, Guru Subramanian

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

评估接受低强度治疗的加速期/急变期骨髓增生性肿瘤患者的基于急性髓系白血病(AML)的风险标准

Shaw, Reid; Yoon, James J; Johnston, Hannah; Davidson, Marta B; Siddon, Alexa J; Shallis, Rory M; Chen, Evan C; Burkart, Madelyn; Oh, Timothy S; Iyer, Sunil G; Madarang, Ellen; Muthiah, Chandrasekar; Kassner, Joshua; Rampal, Raajit K; Guru Murthy, Guru Subramanian; Bradley, Terrence; Abaza, Yasmin; Garcia, Jacqueline S; Gupta, Vikas; Pettit, Kristen M; Odenike, Olatoyosi; Patel, Anand A

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

影响携带TP53突变的髓系肿瘤患者异基因移植后生存率的因素

Baranwal, Anmol; Langer, Kimberly J; Gannamani, Vedavyas; Rud, Danielle; Cibich, Alia; Saygin, Caner; Nawas, Mariam; Badar, Talha; Kharfan-Dabaja, Mohamed A; Ayala, Ernesto; Roy, Vivek; Foran, James M; Murthy, Hemant S; Iqbal, Madiha; Palmer, Jeanne; Sproat, Lisa Z; Chhabra, Saurabh; Khera, Nandita; Hefazi, Mehrdad; Mangaonkar, Abhishek; Hogan, William; Litzow, Mark; Alkhateeb, Hassan; Tefferi, Ayalew; Kok, Chung Hoow; Guru Murthy, Guru Subramanian; Patel, Anand; Bajel, Ashish; Hiwase, Devendra K; Shah, Mithun Vinod

Pathologic Signaling and Disease Implications of Insulin-like Growth Factor Binding Proteins in Cancer, Cardiovascular Disease, and Fibrosis

胰岛素样生长因子结合蛋白在癌症、心血管疾病和纤维化中的病理信号传导和疾病意义

Sechrist, Zachary R; Cortés, Jaeden S; Patel, Nidhi R; Pittman, Zoe J; Guru Murthy, Gayathri; Zhu, Guangzhen; Cole, Calvin L; Korman, Benjamin D

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

IDH1/2突变加速期/急变期骨髓增殖性肿瘤患者的反应和预后

Goldberg, Leah A; Yoon, James J; Johnston, Hannah; Davidson, Marta B; Siddon, Alexa; Shallis, Rory M; Chen, Evan C; Burkart, Madelyn; Oh, Timothy S; Iyer, Sunil G; Madarang, Ellen; Muthiah, Chandrasekar; Kassner, Joshua; Rampal, Raajit K; Guru Murthy, Guru Subramanian; Bradley, Terrence; Abaza, Yasmin; Garcia, Jacqueline S; Gupta, Vikas; Pettit, Kristen M; Odenike, Olatoyosi; Cursio, John F; Patel, Anand A

Postpartum Sterilization after a Preterm Delivery Is Not Associated with Decision Regret

早产后绝育与产后后悔无关

Toscano, Marika; Betstadt, Sarah J; Spielman, Sara; Guru Murthy, Gayathri; Levandowski, Brooke A

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation

蛋白质组学预测接受异基因造血干细胞移植的骨髓增生异常综合征患者的复发

Guru Murthy, Guru Subramanian; Zhang, Tao; Bolon, Yung-Tsi; Spellman, Stephen; Dong, Jing; Auer, Paul; Saber, Wael

Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention

采用门诊方式进行 CAR-T 细胞疗法,策略为不进行远程监测和早期 CRS 干预。

Furqan, Fateeha; Bhatlapenumarthi, Vineel; Dhakal, Binod; Fenske, Timothy S; Farrukh, Faiqa; Longo, Walter; Akhtar, Othman; D'Souza, Anita; Pasquini, Marcelo; Guru Murthy, Guru Subramanian; Runaas, Lyndsey; Abedin, Sameem; Mohan, Meera; Shah, Nirav N; Hamadani, Mehdi

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

当前时代加速期/急变期骨髓增生性肿瘤患者的治疗方法和预后

Patel, Anand A; Yoon, James J; Johnston, Hannah; Davidson, Marta B; Shallis, Rory M; Chen, Evan C; Burkart, Madelyn; Oh, Timothy S; Iyer, Sunil G; Madarang, Ellen; Muthiah, Chandrasekar; Gross, Iyana; Dean, Raven; Kassner, Joshua; Viswabandya, Auro; Madero-Marroquin, Rafael; Rampal, Raajit K; Guru Murthy, Guru Subramanian; Bradley, Terrence; Abaza, Yasmin; Garcia, Jacqueline S; Gupta, Vikas; Pettit, Kristen M; Cursio, John F; Odenike, Olatoyosi